Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ISCT Annual Meeting - Senti Bio has designed a scalable process for efficient manufacturing of allogeneic CAR-NK cell pipeline - - Large scale expansion of PBMC-NK cells and UCB-NK cells may provide a scalable source...

Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at Upcoming Scientific Conferences SOUTH SAN FRANCISCO, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today announced the acceptance of five abstracts for presentation at upcoming virtual...